Literature DB >> 30838505

T188K-Familial Creutzfeldt-Jacob Disease, Predominant Among Chinese, has a Reactive Pattern in CSF RT-QuIC Different from D178N-Fatal Familial Insomnia and E200K-Familial CJD.

Kang Xiao1, Qi Shi2, Wei Zhou1, Bao-Yun Zhang1, Yuan Wang1, Cao Chen1, Yue Ma1, Chen Gao1, Xiao-Ping Dong3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30838505      PMCID： PMC6527617          DOI： 10.1007/s12264-019-00354-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  18 in total

1.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases.

Authors:  Mee-Ohk Kim; Ignazio Cali; Abby Oehler; Jamie C Fong; Katherine Wong; Tricia See; Jonathan S Katz; Pierluigi Gambetti; Brianne M Bettcher; Stephen J Dearmond; Michael D Geschwind
Journal:  Acta Neuropathol Commun       Date:  2013-12-12       Impact factor: 7.801

3.  Fatal familial insomnia: clinical features and molecular genetics.

Authors:  P Cortelli; P Gambetti; P Montagna; E Lugaresi
Journal:  J Sleep Res       Date:  1999-06       Impact factor: 3.981

4.  The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010.

Authors:  Chen Gao; Qi Shi; Chan Tian; Cao Chen; Jun Han; Wei Zhou; Bao-Yun Zhang; Hui-Ying Jiang; Jin Zhang; Xiao-Ping Dong
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

5.  Fatal familial insomnia with an unusual prion protein deposition pattern: an autopsy report with an experimental transmission study.

Authors:  K Sasaki; K Doh-ura; Y Wakisaka; H Tomoda; T Iwaki
Journal:  Neuropathol Appl Neurobiol       Date:  2005-02       Impact factor: 8.090

6.  Clinical, histopathological and genetic studies in a family with fatal familial insomnia.

Authors:  Xiao-Hong Shi; Jun Han; Jin Zhang; Qi Shi; Jian-Ming Chen; Sheng-Li Xia; Zhi-Qiang Xie; Xiao-Jing Shen; Bing Shan; Yan-Jun Lei; Song Shi; Wei Zhou; Bao-Yun Zhang; Chen Gao; Ying-Hui Liu; Juan Song; Yan-Jun Guo; De-Xin Wang; Bian-Li Xu; Xiao-Ping Dong
Journal:  Infect Genet Evol       Date:  2010-01-22       Impact factor: 3.342

7.  Evidence for a pathogenic role of different mutations at codon 188 of PRNP.

Authors:  Sigrun Roeber; Eva-Maria Grasbon-Frodl; Otto Windl; Bjarne Krebs; Wei Xiang; Caren Vollmert; Thomas Illig; Andreas Schröter; Thomas Arzberger; Petra Weber; Inga Zerr; Hans A Kretzschmar
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

Review 8.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

9.  Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.

Authors:  Qi Shi; Chen Gao; Wei Zhou; Bao-Yun Zhang; Jian-Ming Chen; Chan Tian; Hui-Ying Jiang; Jun Han; Ni-Juan Xiang; Xiao-Fang Wang; Yong-Jun Gao; Xiao-Ping Dong
Journal:  BMC Public Health       Date:  2008-10-18       Impact factor: 3.295

10.  Characteristic CSF prion seeding efficiency in humans with prion diseases.

Authors:  Maria Cramm; Matthias Schmitz; André Karch; Saima Zafar; Daniela Varges; Eva Mitrova; Bjoern Schroeder; Alex Raeber; Franziska Kuhn; Inga Zerr
Journal:  Mol Neurobiol       Date:  2014-05-09       Impact factor: 5.590
View more
  8 in total

1.  Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.

Authors:  Qi Shi; Cao Chen; Kang Xiao; Wei Zhou; Li-Ping Gao; Dong-Dong Chen; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  Neurosci Bull       Date:  2021-09-06       Impact factor: 5.203

2.  Application of α-Syn Real-Time Quaking-Induced Conversion for Brain and Skin Specimens of the Chinese Patients With Parkinson's Disease.

Authors:  Dong-Dong Chen; Ling Jiao; Yue Huang; Kang Xiao; Li-Ping Gao; Cao Chen; Qi Shi; Xiao-Ping Dong
Journal:  Front Aging Neurosci       Date:  2022-07-01       Impact factor: 5.702

3.  Different post-mortem brain regions from three Chinese FFI patients induce different reactive profiles both in the first and second generation RT-QuIC assays.

Authors:  Kang Xiao; Qi Shi; Wei Zhou; Xiao-Ping Dong
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

4.  Genetic prion disease: D178N with 129MV disease modifying polymorphism-a clinical phenotype.

Authors:  Tracie Huey-Lin Tan; Richard J Stark; John A Waterston; Owen White; Dominic Thyagarajan; Mastura Monif
Journal:  BMJ Neurol Open       Date:  2020-09-18

5.  Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in PRNP: comparative analysis of patients identified in the Chinese National CJD Surveillance System.

Authors:  Qi Shi; Kang Xiao; Cao Chen; Wei Zhou; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  BMJ Open       Date:  2021-11-15       Impact factor: 2.692

Review 6.  A fatal familial insomnia patient newly diagnosed as having depression: A case report.

Authors:  Tan Yukang; Liang Jiaquan; Li Xiaoling; Liu Yiliang; Xu Guohong; Xu Caixia; Xie Guojun
Journal:  Medicine (Baltimore)       Date:  2021-10-15       Impact factor: 1.889

7.  Alterations of Striatal Subregions in a Prion Protein Gene V180I Mutation Carrier Presented as Frontotemporal Dementia With Parkinsonism.

Authors:  Zhongyun Chen; Jinghong Ma; Li Liu; Shuying Liu; Jing Zhang; Min Chu; Zhen Wang; Piu Chan; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2022-04-15       Impact factor: 5.702

8.  Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD.

Authors:  Kang Xiao; Xuehua Yang; Wei Zhou; Cao Chen; Qi Shi; Xiaoping Dong
Journal:  Pathogens       Date:  2021-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.